<?xml version="1.0" encoding="UTF-8" ?>

<Genomics_ConceptTask>
<TEXT><![CDATA[The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting 
autophagy in advanced atherosclerosis.

Vascular smooth muscle cells (VSMCs) are an important source of foam cells in 
atherosclerosis. The mechanism for VSMC-derived foam cell formation is, however, 
poorly understood. Here, we demonstrate that the P2RY12/P2Y12 receptor is 
important in regulating macroautophagy/autophagy and VSMC-derived foam cell 
formation in advanced atherosclerosis. Inhibition of the P2RY12 receptor 
ameliorated lipid accumulation and VSMC-derived foam cell formation in high-fat 
diet-fed apoe-/- mice (atherosclerosis model) independent of LDL-c levels. 
Activation of the P2RY12 receptor blocked cholesterol efflux via PI3K-AKT, while 
genetic knockdown or pharmacological inhibition of the P2RY12 receptor inhibited 
this effect in VSMCs. Phosphoproteomic analysis showed that the P2RY12 receptor 
regulated the autophagy pathway in VSMCs. Additionally, activation of the P2RY12 
receptor inhibited MAP1LC3/LC3Â maturation, SQSTM1 degradation, and autophagosome 
formation in VSMCs. Genetic knockdown of the essential autophagy gene Atg5 
significantly attenuated P2RY12 receptor inhibitor-induced cholesterol efflux in 
VSMCs. Furthermore, activation of the P2RY12 receptor led to the activation of 
MTOR through PI3K-AKT in VSMCs, whereas blocking MTOR activity (rapamycin) or 
reducing MTOR expression reversed the inhibition of cholesterol efflux mediated 
by the P2RY12 receptor in VSMCs. In vivo, inhibition of the P2RY12 receptor 
promoted autophagy of VSMCs through PI3K-AKT-MTOR in advanced atherosclerosis in 
apoe-/- mice, which could be impeded by an autophagy inhibitor (chloroquine). 
Therefore, we conclude that activation of the P2RY12 receptor decreases 
cholesterol efflux and promotes VSMC-derived foam cell formation by blocking 
autophagy in advanced atherosclerosis. Our study thus suggests that the P2RY12 
receptor is a therapeutic target for treating atherosclerosis.]]></TEXT>
<TAGS>
<PERTURBING_ACTION id="P0" spans="469~502" text="Inhibition of the P2RY12 receptor" description="pharmacological inhibition" />
<PERTURBING_ACTION id="P1" spans="594~601" text="apoe-/-" description="knock out" />
<PERTURBING_ACTION id="P4" spans="743~760,791~813" text="genetic knockdown ... of the P2RY12 receptor" description="knock down" />
<PERTURBING_ACTION id="P5" spans="764~813" text="pharmacological inhibition of the P2RY12 receptor" description="pharmacological inhibition" />
<PERTURBING_ACTION id="P6" spans="962~986" text="activation of the P2RY12" description="other" />
<PERTURBING_ACTION id="P7" spans="1090~1110,1140~1144" text="Genetic knockdown of ... Atg5" description="knock down" />
<PERTURBING_ACTION id="P8" spans="1248~1281" text="activation of the P2RY12 receptor" description="other" />
<PERTURBING_ACTION id="P9" spans="1348~1382" text="blocking MTOR activity (rapamycin)" description="pharmacological inhibition" />
<PERTURBING_ACTION id="P10" spans="1387~1411" text="reducing MTOR expression" description="knock down" />
<PERTURBING_ACTION id="P11" spans="1510~1543" text="inhibition of the P2RY12 receptor" description="pharmacological inhibition" />
<PERTURBING_ACTION id="P12" spans="1627~1634" text="apoe-/-" description="knock out" />
<PERTURBING_ACTION id="P13" spans="1734~1767" text="activation of the P2RY12 receptor" description="other" />
<CONTEXT id="C0" spans="539~543" text="VSMC" experiment_type="cells" species="not stated" />
<CONTEXT id="C1" spans="602~606" text="mice" experiment_type="organism" species="mouse" />
<CONTEXT id="C2" spans="840~845" text="VSMCs" experiment_type="cells" species="not stated" />
<CONTEXT id="C3" spans="941~946" text="VSMCs" experiment_type="cells" species="not stated" />
<CONTEXT id="C4" spans="1083~1088" text="VSMCs" experiment_type="cells" species="not stated" />
<CONTEXT id="C5" spans="1228~1233" text="VSMCs" experiment_type="cells" species="not stated" />
<CONTEXT id="C6" spans="1333~1338" text="VSMCs" experiment_type="cells" species="not stated" />
<CONTEXT id="C10" spans="1635~1639" text="mice" experiment_type="organism" species="mouse" />
<CONTEXT id="C11" spans="1811~1815" text="VSMC" experiment_type="cells" species="not stated" />
<CONTEXT id="C12" spans="1501~1508,1567~1572" text="In vivo ... VSMCs" experiment_type="cells" species="not stated" />
<CONTEXT id="C13" spans="1494~1499" text="VSMCs" experiment_type="cells" species="not stated" />
<EFFECT id="E0" spans="906~937" text="regulated the autophagy pathway" phenotype="autophagy" activity="regulates" />
<EFFECT id="E1" spans="1545~1563" text="promoted autophagy" phenotype="autophagy" activity="increases" />
<EFFECT id="E2" spans="1847~1866" text="blocking  autophagy" phenotype="autophagy" activity="inhibits" />
<ENTITY_LINKING id="EN0" perturbing_actionID="P11" perturbing_actionText="inhibition of the P2RY12 receptor" contextID="C12" contextText="In vivo ... VSMCs" effectID="E1" effectText="promoted autophagy" />
<ENTITY_LINKING id="EN1" perturbing_actionID="P11" perturbing_actionText="inhibition of the P2RY12 receptor" contextID="C10" contextText="mice" effectID="E1" effectText="promoted autophagy" />
<ENTITY_LINKING id="EN2" perturbing_actionID="P13" perturbing_actionText="activation of the P2RY12 receptor" contextID="C11" contextText="VSMC" effectID="E2" effectText="blocking  autophagy" />
</TAGS>
</Genomics_ConceptTask>